| NV group | PS group | P value |
---|---|---|---|
Number of patients | 25 | 25 | – |
Sex (male/female) | 17/8 | 18/7 | 0.76 |
Age (years) | 64.8 ± 9.0 | 63.9 ± 10.2 | 0.59 |
Duration of dialysis (years) | 6.5 ± 3.6 | 6.6 ± 5.1 | 0.69 |
Insulin administration (Y/N) | 10/15 | 10/15 | 1.00 |
Duration of diabetic nephropathy (years) | 19.1 ± 13.0 | 13.9 ± 10.9 | 0.13 |
Administration of DPP-4 inhibitors (Y/N) | 16/9 | 13/12 | 0.39 |
Administration of antihypertensive agents (Y/N) | 16/9 | 17/8 | 0.76 |
Body weight (kg) | 60.8 ± 12.1 | 58.7 ± 11.7 | 0.75 |
HbA1c (%) | 6.2 ± 1.0 | 6.2 ± 0.8 | 0.96 |
Hb (g/dL) | 10.3 ± 0.7 | 10.5 ± 0.6 | 0.89 |
Serum albumin (g/dL) | 3.9 ± 0.4 | 3.9 ± 0.3 | 0.74 |
Surface area of dialyzer (m2) | 1.8 ± 0.4 | 1.8 ± 0.4 | 0.53 |